Post-Mastectomy Radiation Therapy in HER-2 Positive Breast Cancer Patients: Analysis of the HERA Trial

Post-mastectomy radiation therapy (PMRT) improves recurrence rates and overall survival in breast cancer patients. However, it remains unclear whether these findings can be applied to HER-2 positive patients treated with trastuzumab.

Source: International Journal of Radiation Oncology * Biology * Physics - October 21, 2019 Category: Radiology Authors: Joseph Abi Jaoude, Evandro de Azambuja, Maha Makki, Hani Tamim, Arafat Tfayli, Fady Geara, Martine Piccart, Philip Poortmans, Youssef H. Zeidan Source Type: research